Webinar: Mystified by MAT? Navigating the Changing Regulatory Landscape
- Date Recorded: November 1, 2018
- Presenters: Francesca R. Ozinal and Andrew Martin
- Length: about an hour
- Price: free
- Questions/Concerns: email@example.com | 888-958-2282
There is a confluence of national and local public policy developments regarding mental health, substance use disorders, and treatment. The federal government, working in partnership with states, addresses behavioral health issues and establishes and enforces minimum standards. States, however, have significant power in making decisions—mental health regulations and available services can look very different from state to state, and even from county to county.
This was part of a partnership between Behavioral Health Association of Providers, Epstein Becker Green, and Nelson Hardiman: offering a winter / spring webinar series that addressed topics highlighting the accelerating legal and policy issues for the behavioral health industry.
Despite reports identifying medication-assisted treatment (MAT) as a critical element of evidence-based treatment, confusion concerning who may dispense, associated compliance requirements, and the relationship between MAT provision and behavioral health providers continues to impede access to MAT.
This webinar reviews key licensing and operational issues concerning the various types of MAT, including buprenorphine, naltrexone, and methadone, as well as misperceptions and key compliance issues in instituting MAT.
Francesca R. Ozinal
Francesca Ozinal is an Associate in the Health Care and Life Sciences practice of Epstein Becker Green.
Fracesca focuses her practice on such areas as fraud and abuse, telehealth, federal and state regulatory and compliance issues affecting a broad range of health care stakeholders, litigation, government investigations, and due diligence.
Andrew Martin is the former Chief Operating Officer at Behavioral Health Association of Providers (current at the time of recording this webinar).
Andrew’s extensive experience in the addiction treatment industry dates back to 2005 and includes founding and operating Serene Scene Magazine, a monthly magazine with a circulation approaching 30,000 subscribers. He also launched The Evolution of Addiction Treatment Conference, which delivered high level learning to addiction treatment professionals; developed LocateTreatment.com, a directory of addiction treatment resources and information for the United States and Canada; and spearheaded Serene Center, a 36-bed transitional sober living and outpatient treatment facility for those in early recovery.